|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for screening for malignant neoplasm of breast
ICD-10 (CM) Code and Descriptor
|
Z12.39 |
Encounter for other screening for malignant neoplasm of breast
This code is considered unacceptable as a principal diagnosis.
|
Z1239 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 20.20%
|
32.54%
|
13.26%
|
8.83%
|
6.52%
|
4.99%
|
3.93%
|
2.83%
|
2.19%
|
1.54%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.39*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
76641
|
ULTRASOUND BREAST COMPLETE |
8,666
|
8,805
|
|
77067
|
SCR MAMMO BI INCL CAD |
6,854
|
6,854
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
5,773
|
5,787
|
|
77063
|
BREAST TOMOSYNTHESIS BI |
5,522
|
5,522
|
|
C8908
|
MRI W/O FOL W/CONT, BREAST, |
3,972
|
3,972
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
2,781
|
2,781
|
|
G0467
|
FQHC VISIT, ESTAB PT |
2,514
|
2,514
|
|
77066
|
DX MAMMO INCL CAD BI |
2,209
|
2,209
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
1,997
|
1,997
|
|
A9585
|
GADOBUTROL INJECTION |
1,842
|
121,486
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,757
|
1,759
|
|
76642
|
ULTRASOUND BREAST LIMITED |
1,443
|
1,459
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,373
|
1,373
|
|
77065
|
DX MAMMO INCL CAD UNI |
1,334
|
1,335
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
1,112
|
1,112
|
|
77080
|
DXA BONE DENSITY AXIAL |
1,106
|
1,106
|
|
80061
|
LIPID PANEL |
1,088
|
1,088
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,054
|
1,054
|
|
C8937
|
CAD BREAST MRI |
973
|
974
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
966
|
120,232
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.39 related to the following DRG Codes:
951
|
